A role for coding functional variants in HNF4A in type 2 diabetes susceptibility.
AIMS/HYPOTHESIS: Rare mutations in the gene HNF4A, encoding the transcription factor hepatocyte nuclear factor 4α (HNF-4A), account for ~5% of cases of MODY and more frequent variants in this gene may be involved in multifactorial forms of diabetes. Two low-frequency, non-synonymous variants in HNF...
| Główni autorzy: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Język: | English |
| Wydane: |
2011
|
| _version_ | 1826293378987327488 |
|---|---|
| author | Jafar-Mohammadi, B Groves, C Gjesing, A Herrera, B Winckler, W Stringham, H Morris, A Lauritzen, T Doney, A Morris, A Weedon, M Swift, A Kuusisto, J Laakso, M Altshuler, D Hattersley, A Collins, F Boehnke, M Hansen, T Pedersen, O Palmer, C Frayling, T Gloyn, A McCarthy, M |
| author_facet | Jafar-Mohammadi, B Groves, C Gjesing, A Herrera, B Winckler, W Stringham, H Morris, A Lauritzen, T Doney, A Morris, A Weedon, M Swift, A Kuusisto, J Laakso, M Altshuler, D Hattersley, A Collins, F Boehnke, M Hansen, T Pedersen, O Palmer, C Frayling, T Gloyn, A McCarthy, M |
| author_sort | Jafar-Mohammadi, B |
| collection | OXFORD |
| description | AIMS/HYPOTHESIS: Rare mutations in the gene HNF4A, encoding the transcription factor hepatocyte nuclear factor 4α (HNF-4A), account for ~5% of cases of MODY and more frequent variants in this gene may be involved in multifactorial forms of diabetes. Two low-frequency, non-synonymous variants in HNF4A (V255M, minor allele frequency [MAF] ~0.1%; T130I, MAF ~3.0%)-known to influence downstream HNF-4A target gene expression-are of interest, but previous type 2 diabetes association reports were inconclusive. We aimed to evaluate the contribution of these variants to type 2 diabetes susceptibility through large-scale association analysis. METHODS: We genotyped both variants in at least 5,745 cases and 14,756 population controls from the UK and Denmark. We also undertook an expanded association analysis that included previously reported and novel genotype data obtained in Danish, Finnish, Canadian and Swedish samples. A meta-analysis incorporating all published association studies of the T130I variant was subsequently carried out in a maximum sample size of 14,279 cases and 26,835 controls. RESULTS: We found no association between V255M and type 2 diabetes in either the initial (p = 0.28) or the expanded analysis (p = 0.44). However, T130I demonstrated a modest association with type 2 diabetes in the UK and Danish samples (additive per allele OR 1.17 [95% CI 1.08-1.28]; p = 1.5 × 10⁻⁴), which was strengthened in the meta-analysis (OR 1.20 [95% CI 1.10-1.30]; p = 2.1 × 10⁻⁵). CONCLUSIONS/INTERPRETATION: Our data are consistent with T130I as a low-frequency variant influencing type 2 diabetes risk, but are not conclusive when judged against stringent standards for genome-wide significance. This study exemplifies the difficulties encountered in association testing of low-frequency variants. |
| first_indexed | 2024-03-07T03:29:11Z |
| format | Journal article |
| id | oxford-uuid:ba1986cb-0bff-4dcd-b200-c879413f98f8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:29:11Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:ba1986cb-0bff-4dcd-b200-c879413f98f82022-03-27T05:07:44ZA role for coding functional variants in HNF4A in type 2 diabetes susceptibility.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ba1986cb-0bff-4dcd-b200-c879413f98f8EnglishSymplectic Elements at Oxford2011Jafar-Mohammadi, BGroves, CGjesing, AHerrera, BWinckler, WStringham, HMorris, ALauritzen, TDoney, AMorris, AWeedon, MSwift, AKuusisto, JLaakso, MAltshuler, DHattersley, ACollins, FBoehnke, MHansen, TPedersen, OPalmer, CFrayling, TGloyn, AMcCarthy, M AIMS/HYPOTHESIS: Rare mutations in the gene HNF4A, encoding the transcription factor hepatocyte nuclear factor 4α (HNF-4A), account for ~5% of cases of MODY and more frequent variants in this gene may be involved in multifactorial forms of diabetes. Two low-frequency, non-synonymous variants in HNF4A (V255M, minor allele frequency [MAF] ~0.1%; T130I, MAF ~3.0%)-known to influence downstream HNF-4A target gene expression-are of interest, but previous type 2 diabetes association reports were inconclusive. We aimed to evaluate the contribution of these variants to type 2 diabetes susceptibility through large-scale association analysis. METHODS: We genotyped both variants in at least 5,745 cases and 14,756 population controls from the UK and Denmark. We also undertook an expanded association analysis that included previously reported and novel genotype data obtained in Danish, Finnish, Canadian and Swedish samples. A meta-analysis incorporating all published association studies of the T130I variant was subsequently carried out in a maximum sample size of 14,279 cases and 26,835 controls. RESULTS: We found no association between V255M and type 2 diabetes in either the initial (p = 0.28) or the expanded analysis (p = 0.44). However, T130I demonstrated a modest association with type 2 diabetes in the UK and Danish samples (additive per allele OR 1.17 [95% CI 1.08-1.28]; p = 1.5 × 10⁻⁴), which was strengthened in the meta-analysis (OR 1.20 [95% CI 1.10-1.30]; p = 2.1 × 10⁻⁵). CONCLUSIONS/INTERPRETATION: Our data are consistent with T130I as a low-frequency variant influencing type 2 diabetes risk, but are not conclusive when judged against stringent standards for genome-wide significance. This study exemplifies the difficulties encountered in association testing of low-frequency variants. |
| spellingShingle | Jafar-Mohammadi, B Groves, C Gjesing, A Herrera, B Winckler, W Stringham, H Morris, A Lauritzen, T Doney, A Morris, A Weedon, M Swift, A Kuusisto, J Laakso, M Altshuler, D Hattersley, A Collins, F Boehnke, M Hansen, T Pedersen, O Palmer, C Frayling, T Gloyn, A McCarthy, M A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. |
| title | A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. |
| title_full | A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. |
| title_fullStr | A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. |
| title_full_unstemmed | A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. |
| title_short | A role for coding functional variants in HNF4A in type 2 diabetes susceptibility. |
| title_sort | role for coding functional variants in hnf4a in type 2 diabetes susceptibility |
| work_keys_str_mv | AT jafarmohammadib aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT grovesc aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT gjesinga aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT herrerab aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT wincklerw aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT stringhamh aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT morrisa aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT lauritzent aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT doneya aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT morrisa aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT weedonm aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT swifta aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT kuusistoj aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT laaksom aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT altshulerd aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT hattersleya aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT collinsf aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT boehnkem aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT hansent aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT pederseno aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT palmerc aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT fraylingt aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT gloyna aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT mccarthym aroleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT jafarmohammadib roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT grovesc roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT gjesinga roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT herrerab roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT wincklerw roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT stringhamh roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT morrisa roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT lauritzent roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT doneya roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT morrisa roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT weedonm roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT swifta roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT kuusistoj roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT laaksom roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT altshulerd roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT hattersleya roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT collinsf roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT boehnkem roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT hansent roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT pederseno roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT palmerc roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT fraylingt roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT gloyna roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility AT mccarthym roleforcodingfunctionalvariantsinhnf4aintype2diabetessusceptibility |